A global expert on the evidence for medicinal cannabis is visiting New Zealand for the first time in February to share the most recent evidence with health professionals across the country and progress work with a New Zealand medicinal cannabis company.
Dr Russo was Senior Medical Advisor and study physician to GW Pharmaceuticals in the United Kingdom for numerous clinical trials of the only Medsafe-registered cannabis-derived medicine, Sativex®, and was also involved in initial studies of Epidiolex®, the only CBD medicine currently approved by the US FDA.
Dr Ethan Russo is a board-certified neurologist, psychopharmacology researcher, author and Medical Advisor to New Zealand’s first and largest licensed medicinal cannabis company, Rua Bioscience.
Dr Russo will also be meeting with researchers and regulators to discuss New Zealand’s new Medicinal Cannabis Scheme.
This talk is tailored for medical professionals but is open to the public. Registration is free but essential.
|Date||Thursday, 27 February 2020|
|Time||6:30pm - 8:30pm|
|Event Category||Health Sciences|
|Department||Public Health (Wellington)|
|Location||University of Otago, Wellington campus, 23A Mein Street, Newtown, Wellington|